Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108129478B details a copper-catalyzed method for sulfone synthesis using DABSO, offering cost reduction and high purity for pharmaceutical manufacturing.
Novel Rh-catalyzed C-H activation route for antitumor indolopyranones. High purity, scalable process for pharmaceutical intermediates.
Patent CN107935882B reveals a mild Bronsted acid catalyzed route for high-purity azo compounds, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel Rh-catalyzed C-H activation route for high-purity organic optoelectronic materials. Reduces steps and enhances supply chain reliability for electronic chemical manufacturing.
Patent CN1323293A details a high-yield regioselective synthesis of N-substituted hydroxycycloalkylamines using 1,2-cyclosulfinyl alkyl halides, offering significant cost reduction in API manufacturing.
Patent CN108164397A reveals a mild C-H activation route for catechol derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107382894B details a novel one-pot synthesis of o-benzophenone benzoxazole derivatives using Pd/norbornene catalysis, offering significant cost reduction in API manufacturing.
Patent CN118619960A reveals ligand-assisted C-H activation for indole alkaloids, enhancing yield and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115010715B reveals a Ru-catalyzed route for indolobenzodiazepines. Discover cost reduction in anticancer drug manufacturing and reliable pharmaceutical intermediate supplier solutions.
Patent CN108299340A enables mild Pd-catalyzed fluorination. Delivers high-purity pharmaceutical intermediates with significant supply chain cost reduction advantages.
Patent CN113461681A reveals efficient iridium-catalyzed C-H amination using ionic liquids, offering high purity pharmaceutical intermediates with reduced processing costs.
Patent CN103044415A details a novel acyl chloride route for Aztreonam, eliminating strong acid damage and enhancing purity for reliable pharmaceutical intermediate supply chains.
Patent CN104177357B details a Rh-catalyzed isoquinoline salt synthesis using oxygen. This method offers high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Novel C-H activation patent CN117603131A enables high-purity pyridine intermediates with reduced costs and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN108997193A reveals cobalt-catalyzed route offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN110845363B details a Rh-catalyzed C-H activation route for o-alkenyl nitriles. Offers cost reduction in pharmaceutical intermediate manufacturing with high selectivity.
Novel C-H activation method for Acyclovir and Ganciclovir synthesis. Delivers high yield, cost-effective production, and scalable supply chain solutions for global pharmaceutical manufacturers seeking reliable intermediates.
Patent CN117801004A details Pd-catalyzed C-H activation for indole functionalization, offering high yield and mild conditions for supply chain optimization.
Patent CN113651663A reveals a green one-pot palladium-catalyzed method for ortho-deuteration, offering reliable supply chain solutions and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106831765A reveals Rhodium-catalyzed cyanation for high-purity imidazopyridine intermediates. Achieve cost reduction in pharmaceutical intermediate manufacturing with scalable methods.